CD28 and neoplasm: Shin et al7 reported that the cytotoxic T-lymphocyte-associated protein 4 (CTLA4)-CD28 chimera, consisting of the extracellular and transmembrane domains of CTLA4 and the cytoplasmic domain of CD28, enhanced the activity of tumor-specific T cells.